- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/04 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
Patent holdings for IPC class C07D 243/04
Total number of patents in this class: 38
10-year publication summary
3
|
1
|
3
|
1
|
0
|
4
|
2
|
1
|
2
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Boehringer Ingelheim International GmbH | 4640 |
4 |
Vitae Pharmaceuticals, Inc. | 96 |
3 |
Washington University | 1622 |
3 |
Merck Sharp & Dohme LLC | 3750 |
3 |
Bitop AG | 50 |
2 |
Bristol-myers Squibb Company | 4867 |
1 |
The Regents of the University of California | 20035 |
1 |
Boehringer Ingelheim Pharma GmbH & Co. Kg | 542 |
1 |
FUJIFILM Corporation | 29506 |
1 |
The Board of Trustees of the University of Illinois | 2711 |
1 |
Vertex Pharmaceuticals Incorporated | 1619 |
1 |
Arizona Board of Regents on behalf of Arizona State University | 2658 |
1 |
Blueprint Medicines Corporation | 237 |
1 |
Calithera Biosciences, Inc. | 41 |
1 |
Central Glass Company, Limited | 1271 |
1 |
Cornell University | 3322 |
1 |
Firmenich SA | 1688 |
1 |
Heptares Therapeutics Limited | 74 |
1 |
Huntsman Petrochemical LLC | 294 |
1 |
Mitsubishi Tanabe Pharma Corporation | 581 |
1 |
Other owners | 8 |